Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide
100%
6 N,n' Dimethylarginine
73%
N(g),n(g) Dimethylarginine
73%
Peripheral Occlusive Artery Disease
61%
Cardiovascular Disease
51%
Messenger RNA
48%
Nitric Oxide Synthase
46%
Atherosclerosis
45%
Diseases
43%
Endothelial Dysfunction
31%
Atherogenesis
30%
Leporidae
29%
Dimethylargininase
27%
Malignant Neoplasm
27%
Nicotinic Receptor
26%
Vasculotropin
25%
Clinical Trial
22%
Ischemia
22%
Cardiovascular Risk
21%
Vascular Disease
20%
Congestive Heart Failure
19%
Cholinergic Receptor Stimulating Agent
17%
Proton Pump Inhibitor
17%
Acetylcholine
17%
Inflammation
16%
Heart Infarction
16%
Endothelium Derived Relaxing Factor
15%
Neoplasm
14%
Neovascularization (Pathology)
13%
Nanoparticle
12%
Coronary Artery Disease
12%
All Cause Mortality
11%
Homocysteine
11%
Diabetes Mellitus
11%
Pathophysiology
10%
Telomerase
10%
Table Salt
10%
S Nitrosocaptopril
10%
Vasculitis
10%
Growth Factor
10%
Insulin Resistance
10%
Cytokine
9%
Placebo
9%
Mouse Model
9%
Prostacyclin
8%
Superoxide
8%
Functional Status
8%
Prematurity
8%
Wound Healing
8%
Receptor
8%
Medicine and Dentistry
Nitric Oxide
64%
Endothelial Cell
50%
Atherosclerosis
48%
Arteriosclerosis Obliterans
47%
Cardiovascular Disease
40%
Messenger RNA
35%
Cardiovascular System
35%
N(g),n(g) Dimethylarginine
32%
Endothelial Dysfunction
29%
Nitric Oxide Synthase
27%
Angiogenesis
26%
Diseases
23%
Congestive Heart Failure
21%
Vasodilatation
20%
Vascular Disease
19%
Atherogenesis
19%
Induced Pluripotent Stem Cell
18%
Hindlimb
18%
Ischemia
17%
Proton-Pump Inhibitor
17%
Endothelial Function
17%
Cardiovascular Risk
17%
Blood Vessel Reactivity
15%
In Vitro
15%
Telomerase
14%
Mononuclear Cell
13%
Cell Therapy
13%
Vascularity
13%
Malignant Neoplasm
13%
Vascular Medicine
12%
Clinical Trial
12%
Wound Healing
12%
Vascular Smooth Muscle Cell
11%
Myocardial Infarction
11%
Coronary Artery Disease
11%
Diabetes Mellitus
11%
Macrophage
11%
Dimethylargininase
11%
Supplementation
10%
Arteriogenesis
10%
Infection
10%
Cardiac Allograft Vasculopathy
10%
Cancer Therapy
10%
Diabetes
10%
Fibroblast
9%
Acetylcholine
9%
Limb
9%
Cytomegalovirus
9%
Transplantation
9%
Cholesterol Diet
8%
Keyphrases
Peripheral Arterial Disease
29%
Asymmetric Dimethylarginine
28%
Cardiovascular Disease
23%
Nitric Oxide
23%
Endothelial Dysfunction
22%
Monocytes
20%
Endothelium
18%
Hypercholesterolemic Rats
18%
Endothelial Nitric Oxide
16%
Angiogenesis
15%
Endothelial Cells
14%
Endothelium-dependent Relaxation
13%
Senescence-associated Secretory Phenotype
13%
Endothelial Function
10%
Arteriogenesis
10%
Vascular Regeneration
10%
Inducible Nitric Oxide Synthase
9%
Clinical Trials
9%
Vascular Smooth muscle Cells
8%
Cancer Treatment
8%
Transdifferentiation
8%
Cell Therapy
8%
Mononuclear Cells
8%
Age-related Illnesses
8%
Vascular Reactivity
8%
Lesion Formation
8%
Vascular Disease
7%
Vascular Cells
7%
Vasodilator
7%
Cardiovascular Risk
7%
Telomerase
7%
Nitric Oxide Production
7%
Induced Pluripotent Stem Cells (iPSCs)
7%
Neointimal Lesion
7%
Endothelial Nitric Oxide Synthase (eNOS)
7%
Atherogenesis
7%
RNA Therapeutics
7%
Atherosclerosis Regression
7%
Fibroblasts
7%
Premature Senescence
7%
Vessel Integrity
7%
Progeria Syndrome
7%
Felodipine
7%
Induced Endothelial Cells
7%
Pasteur's Quadrant
7%
Endothelial Senescence
7%
S-nitrosocaptopril
7%
Transflammation
7%
Nuclear Reprogramming
7%
Proton Pump Inhibitors
7%